Table 1

Patient characteristics of pre-MDT and post-MDT cohorts

Patient characteristicsPre-MDT group (n=26)Post-MDT group (n=46)P value
Gender (% male)73.169.60.794
Age (years)69.0±1.872.3±1.80.197
Smoking history (number of patients)0.409
 Current01
 Ex-smoker1329
 Never1214
 Unknown12
FVC (% predicted)59.2±2.4, n=2558.6±2.3, n=450.856
TLCO (% predicted)28.3±2.2, n=1632.9±2.1, n=270.140
6MWT distance (m)184.2±20.6, n=23186.5±13.8, n=430.927
Minimum saturation on 6MWT (%)80.8±1.7, n=2382.98±1.0, n=430.294
Oxygen dependency (number of patients)0.415
 LTOT1532
 Ambulatory OT711
 None41
 Declined02
NT-proBNP (pg/mL)1283±614.2, n=111223±305.9, n=380.931
ECHO suggestion of raised pulmonary pressures3(n=13)8 (n=34)0.999
  • Baseline demographics of pre-MDT (n=26) and post-MDT (n=46) cohorts were statistically comparable. Patients had moderately severe disease as determined by their lung function, with high dependency on oxygen and evidence of raised NT-proBNP. Data presented as mean±SEM unless otherwise stated.

  • Ambulatory OT, ambulatory oxygen therapy; ECHO, echocardiogram; FVC, Forced Vital Capacity; LTOT, long-term oxygen therapy; MDT, multidisciplinary team; 6MWT, 6-min walk test; NT-proBNP, N-terminal pro B-type natriuretic peptide; TLCO, gas transfer of the lung for carbon monoxide.